Chemed Corporation $CHE is LRT Capital Management LLC’s 7th Largest Position

LRT Capital Management LLC lifted its position in Chemed Corporation (NYSE:CHE) by 27.2% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 8,821 shares of the company’s stock after purchasing an additional 1,887 shares during the period. Chemed accounts for approximately 2.6% of LRT Capital Management LLC’s investment portfolio, making the stock its 7th largest holding. LRT Capital Management LLC’s holdings in Chemed were worth $3,949,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the company. Smartleaf Asset Management LLC increased its position in Chemed by 71.4% during the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after acquiring an additional 25 shares during the last quarter. First Horizon Corp bought a new stake in shares of Chemed during the 3rd quarter valued at about $31,000. Geneos Wealth Management Inc. grew its stake in shares of Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after purchasing an additional 76 shares during the period. Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Chemed during the 3rd quarter valued at about $45,000. Finally, HM Payson & Co. lifted its stake in shares of Chemed by 35.5% in the 3rd quarter. HM Payson & Co. now owns 103 shares of the company’s stock worth $46,000 after purchasing an additional 27 shares during the period. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Down 0.7%

NYSE CHE opened at $398.87 on Tuesday. Chemed Corporation has a twelve month low of $385.00 and a twelve month high of $623.60. The business has a 50-day moving average price of $440.69 and a 200-day moving average price of $440.44. The firm has a market cap of $5.49 billion, a price-to-earnings ratio of 21.71, a price-to-earnings-growth ratio of 1.59 and a beta of 0.47.

Chemed (NYSE:CHE) last issued its earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.02 by ($0.60). Chemed had a net margin of 10.48% and a return on equity of 25.66%. The business had revenue of $639.34 million for the quarter, compared to the consensus estimate of $659.09 million. During the same period last year, the business posted $6.83 EPS. The firm’s revenue for the quarter was down .1% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. Research analysts expect that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were given a dividend of $0.60 per share. The ex-dividend date was Monday, February 23rd. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed’s dividend payout ratio (DPR) is presently 13.06%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. Jefferies Financial Group lowered shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Royal Bank Of Canada reissued a “sector perform” rating and set a $422.00 price objective (down from $572.00) on shares of Chemed in a research report on Friday, February 27th. Zacks Research lowered Chemed from a “hold” rating to a “strong sell” rating in a report on Wednesday, March 4th. Finally, Oppenheimer reduced their price target on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. Two investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Chemed currently has an average rating of “Hold” and an average price target of $498.00.

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $403.18, for a total value of $806,360.00. Following the transaction, the chief executive officer owned 93,719 shares of the company’s stock, valued at approximately $37,785,626.42. The trade was a 2.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 3.29% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.